New Oral Treatment Approved for Relapsing Forms of MS
The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the United States Food and Drug Administration (FDA) approved Ponvory™ (ponesimod) for the treatment of relapsing forms of multiple sclerosis (MS) in adults — including clinically isolated syndrome, relapsing-remitting, and active secondary-progressive forms of MS.
The ability to reply to this post has been turned off.
Thank you for posting this item, I read it through, I tried to send it to a friend, it said the email address was invalid, but I know it’s not?????
It works for my computer. Hmmm. Try searching for "MSAA"
Thank you for this really useful link to the Multiple Schlerosis Association of America's article about this new drug which I see will be available in America on prescription from April of this year.We won't know for a while whether it will be approved for use in the United Kingdom, but it's always good to learn what new treatments are coming on-line, and must bring big fresh hope to sufferers of this horrible condition. Thanks for sharing.
.Thank you for posting this marvellous news, I spent many years working on MS Clinical trials prior to my stroke and subsequent retirement from theNHS and I am sure this will change the lives of many of my previous patients who I got to meet all of whom were desperate for any form of treatment for this debilitating illness
The ability to reply to this post has been turned off.
Seeing a new wave of life 
a new update - TheDrivenSnow
HAPPY NEW YEAR ROUKAYA